Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3757769019 | Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3757770018 | Cyclizine hydrochloride 30 mg and dipipanone hydrochloride 10 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4639171000052111 | cyklizinhydroklorid 30 milligram och dipipanonhydroklorid 10 milligram, oral tablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Cyclizine and dipipanone only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Cyclizine hydrochloride (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Dipipanone hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Cyclizine hydrochloride (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | 30 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | 10 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclizine hydrochloride 30 milligram and dipipanone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Dipipanone hydrochloride | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR